APA Alıntı

Shah, C., Mramba, L. K., Bishnoi, R., Bejjanki, H., Chhatrala, H. S., & Chandana, S. R. (2017). Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: Pre and post sorafenib era. J Gastrointest Oncol.

Chicago Stili Alıntı

Shah, Chintan, Lazarus K. Mramba, Rohit Bishnoi, Harini Bejjanki, Hardik Satish Chhatrala, ve Sreenivasa R. Chandana. "Survival Differences Among Patients With Hepatocellular Carcinoma Based On the Stage of Disease and Therapy Received: Pre and Post Sorafenib Era." J Gastrointest Oncol 2017.

MLA Alıntı

Shah, Chintan, et al. "Survival Differences Among Patients With Hepatocellular Carcinoma Based On the Stage of Disease and Therapy Received: Pre and Post Sorafenib Era." J Gastrointest Oncol 2017.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..